Table 2.
Treatment of asthma in adults and children aged 5 years and younger*
Step | Long-term control | Quick relief |
---|---|---|
Step 4: Severe persistent |
|
Short-acting bronchodilator: β2-agonists as needed (inhaled or oral) |
Step 3: Moderate persistent | Anti-inflammatory drug: inhaled corticosteroid (medium dose) with or without nedocromil sodium or theophylline | Short-acting bronchodilator: β2-agonists as needed (inhaled or oral). If using >2 × /wk, consider increasing to the next step |
Step 2: Mild persistent | Anti-inflammatory drug: mast cell stabilizer or inhaled corticosteroids (low dose) | Short-acting bronchodilator: β2-agonists as needed (inhaled or oral). If using >2 × /wk, consider increasing to the next step |
Step 1: Mild intermittent | No daily medicines needed | Short-acting bronchodilator: β2-agonists as needed (inhaled or oral). If using >2 × /wk, consider increasing to the next step |
From the National Asthma Education and Prevention Program.3